Rani Therapeutics Hldgs Stock (NASDAQ: RANI) stock price, news, charts, stock research, profile.
Open | $3.10 |
Close | $3.03 |
Volume / Avg. | 20.31K / 93.59K |
Day Range | 3.00 - 3.22 |
52 Wk Range | 1.82 - 8.75 |
Market Cap | $79.70M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 5.76% |
Days to Cover | 12.94 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rani Therapeutics Hldgs (NASDAQ:RANI) through any online brokerage.
Other companies in Rani Therapeutics Hldgs’s space includes: Universe Pharmaceuticals (NASDAQ:UPC), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Marinus Pharma (NASDAQ:MRNS) and Nutriband (NASDAQ:NTRB).
There is no analysis for Rani Therapeutics Hldgs.
Rani Therapeutics Hldgs has a consensus price target of $15.55.
The stock price for Rani Therapeutics Hldgs (NASDAQ: RANI) is $3.03 last updated July 23, 2024 at 4:14 PM EDT.
There are no upcoming dividends for Rani Therapeutics Hldgs.
Rani Therapeutics Hldgs’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Rani Therapeutics Hldgs.
Rani Therapeutics Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.